Medicine, Gastroenterology Division

Grants

Grants per year 2001 2014 2015 2016 2017 2018 2019 2020 2028

• 61 Active
• 168 Finished

Grants per year

Search results

• Finished

  Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Multi-Center, Randomized, Double-Blind, Sham Controlled Trial (HBOT-UC)

  Bonner, L. B. & Dulai, P. S.

  National Institute of Diabetes and Digestive and Kidney Diseases

  3/15/22 → 8/31/22

  Project: Research project

  • Ulcerative Colitis 100%
  • Hyperbaric Medicine 75%
  • Patient 55%
  • therapy 38%
  • oxygen 38%

• Validation of a Machine Learning Algorithm to Assess Colonoscopic Disease Activity in Inflammatory Bowel Disease

  Bellaguarda, E. A. L., Keswani, R. N. & Bellaguarda, E. A. L.

  Virgo Surgical Video Solutions, Inc

  6/15/21 → 10/31/22

  Project: Research project

  • Disease Activity 100%
  • Inflammatory Bowel Disease 72%
  • diseases 72%
  • Crohn's Disease 66%
  • Colon Polyp 33%

• CF Adult Nutrition Planning Grant

  Stein, A. C.

  Beth Israel Deaconess Medical Center, Cystic Fibrosis Foundation

  10/1/20 → 9/30/22

  Project: Research project

  • Transplantation 100%
  • Frailty 80%
  • Adult 80%
  • Sarcopenia 40%
  • Malnutrition 40%

• Use of Endoscopic Functional Lumen Imaging Probe and Antroduodenal Manometry in Predicting Clinical Response to Gastric Peroral Endoscopic Myotomy

  Aadam, A. A.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/20 → 8/31/22

  Project: Research project

  • Peroral Endoscopic Myotomy 100%
  • Manometry 100%
  • Probe 66%
  • Stomach Paresis 50%
  • Imaging 33%

• Molecular profiling of scleroderma esophageal disease

  Tetreault, M.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/20 → 6/30/21

  Project: Research project

• A missing piece of the puzzle: Patient and provider perspectives on opioid use and pain management in inflammatory bowel disease care

  Stulberg, J. J. & Balbale, S. N.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/20 → 8/31/21

  Project: Research project

  • Opiate 100%
  • Inflammatory Bowel Disease 42%
  • Patient 18%
  • Intoxication 14%
  • Gastrointestinal Disease 14%

• Additive Value of Wide-Area Transepithelial Sampling (WATS3D) in Detection of Recurrence of Intestinal Metaplasia Following Endoscopic Eradication Therapy (EET) for Barrett’s Esophagus Related Neoplasia

  Komanduri, S. & Kwasny, M. J.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/20 → 6/30/21

  Project: Research project

• Open-Label Assessment of the Efficacy of Atrantil in the Treatment of Methane-Predominate Intestinal Bacterial Overgrowth.

  Brenner, D. M. & Cai, J. X.

  Northwestern Memorial Hospital, Digestive Health Foundation

  6/1/20 → 6/30/22

  Project: Research project

• Protocol I6T-MC-AMAN: A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 1

  Hanauer, S. B.

  Quintiles, Inc., Eli Lilly and Company

  4/1/20 → 6/30/22

  Project: Research project

• Predictors of Treatment Response to Swallowed Steroids in Adults with EoE

  Wechsler, J. B. & Gonsalves, N. P.

  Northwestern Memorial Hospital

  1/1/20 → 12/31/21

  Project: Research project

  • Eosinophilic Esophagitis 100%
  • Corticosteroid 100%
  • Biological Marker 66%
  • Treatment Response 66%
  • Predictor 66%

• Machine Learning for Automated, Video-Based Measurement of Colonoscopy Skill to Reduce Colorectal Cancer (CRC) Risk

  Keswani, R. N. & Yang, A. D.

  Gordon E. and Betty I. Moore Foundation

  12/5/19 → 6/30/21

  Project: Research project

• ZP1848-17111, A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Glepaglutide in Patients with Short Bowel Syndrome (SBS)

  Stein, A. C.

  Pharm-Olam International Ltd., Zealand Pharma A/S

  9/26/19 → 9/29/22

  Project: Research project

• Northwestern University Clinical Outcome Assessment Team (NUCOAT)

  Cella, D., Flores, A. M., Gershon, R., Greene, G. J., Griffith, J. W., Lai, J., Nowinski, C. J., Pandolfino, J. E., Peipert, D., Phillips, S. M., Shaunfield, S. & Taft, T. N.

  Food and Drug Administration

  9/10/19 → 8/31/22

  Project: Research project

  • Outcome Assessment 100%
  • Clinical Outcome 80%
  • Patient-Reported Outcome 70%
  • Physical Function 65%
  • assessments 34%

• 5-laser 30-parameter FACSymphony-S6 SORP Cell Sorter from BD Biosciences

  Perlman, H. R., Abecassis, M. M., Bharat, A., Budinger, G. S., D'Aquila, R. T., Hope, T. J., Kato, A., Le Poole, I. C., Lesniak, M. S., Luo, X., Misharin, A., Schleimer, R. P., Singer, B., Swaminathan, S., Sznajder, J. I., Tetreault, M., Thorp, E. B. & Wunderink, R. G.

  Office of the Director, National Institutes of Health

  8/8/19 → 8/7/20

  Project: Research project

  • Translational Research 100%
  • Clinical Outcome 83%
  • Scientific Discovery 83%
  • Cells 66%
  • Cell Type 50%

• Protocol M14-234: A Multicenter, Randomized, Double-Blind, Placebo -Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

  Bellaguarda, E. A. L. & Hanauer, S. B.

  AbbVie Inc.

  7/23/19 → 7/23/22

  Project: Research project

• Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis

  Gottardi, C., Misharin, A., Tetreault, M. & Winter, D. R.

  Yale University, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/3/19 → 6/30/22

  Project: Research project

• Molecular mechanisms involved in early eosinophilic esophagitis pathogenesis

  Tetreault, M.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/19 → 6/30/20

  Project: Research project

• Tailoring Enhanced Recovery Protocols for Children Undergoing Surgery for Inflammatory Bowel Disease: A Qualitative Assessment

  Raval, M. V. & Balbale, S. N.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/19 → 6/30/21

  Project: Research project

  • Patient with Ulcerative Colitis 100%
  • Patient with Inflammatory Bowel Disease 100%
  • Ulcerative Colitis 87%
  • Diseases 87%
  • Digestive System Surgery 87%

• Semen quality in males with inflammatory bowel disease and inflammatory joint disease: Influence of ustekinumab and tofacitinib treatment

  Bellaguarda, E. A. L.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/19 → 6/30/21

  Project: Research project

• Assessing the Effects of Opioids on the Esophagus

  Carlson, D. A.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/19 → 6/30/21

  Project: Research project

• Transpyloric Stenting for Refractory Gastroparesis prior to Gastric Per-Oral Endoscopic Myotomy: A Multicenter Prospective Sham Study

  Aadam, A. A.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/19 → 6/30/21

  Project: Research project

• The Use of Simulation-based mastery learning to improve colonoscopy polypectomy outcomes

  Komanduri, S., Barsuk, J. H. & Cameron, K. A.

  Northwestern Memorial Hospital

  7/1/19 → 6/30/21

  Project: Research project

• Biomechanical assessment of the esophagogastric junction and application of predictive analytics to enhance evaluation of functional dysphagia

  Carlson, D. A. & Kou, W.

  American College of Gastroenterology

  7/1/19 → 6/30/22

  Project: Research project

  • Plummer-Vinson Syndrome 100%
  • Probe 75%
  • esophagus 40%
  • High Resolution Manometry 37%
  • Esophagus Motility 37%

• Prevalence and Determinants of Illness-Related Post Traumatic Stress (PTS) in Inflammatory Bowel Disease Patients

  Taft, T. N. & Quinton, S.

  Northwestern Memorial Hospital, Digestive Health Foundation

  7/1/19 → 6/30/21

  Project: Research project

• Protocol M15-991: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Assess the efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease Who failed Prior Biologic Treatment (Abbvie M15-

  Bellaguarda, E. A. L.

  AbbVie Inc.

  6/14/19 → 6/14/22

  Project: Research project